{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:31:20Z","timestamp":1786995080461,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.numecd.2023.01.025","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T12:38:17Z","timestamp":1676551097000},"page":"925-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High lipoprotein(a) levels and mitral valve disease: A systematic review"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5620-6468","authenticated-orcid":false,"given":"Walter","family":"Masson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-1083","authenticated-orcid":false,"given":"Leandro","family":"Barbagelata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-2375","authenticated-orcid":false,"given":"Pablo","family":"Oberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Lavalle-Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-4700","authenticated-orcid":false,"given":"Juan P.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.01.025_bib1","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.3390\/jcm11206040","article-title":"Lipoprotein(a): evidence for role as a causal risk factor in cardiovascular disease and emerging therapies","volume":"11","author":"Bhatia","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2023.01.025_bib2","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2023.01.025_bib3","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2023.01.025_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.116.026103","article-title":"A replicated, genome-wide significant association of aortic stenosis with a genetic variant for lipoprotein(a): meta-analysis of published and novel data","volume":"135","author":"Cairns","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.01.025_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/ATVBAHA.115.306683","article-title":"Lipoprotein(a) levels are associated with subclinical calcific aortic valve disease in white and black individuals: the multi-ethnic study of atherosclerosis","volume":"36","author":"Cao","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2023.01.025_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7775\/rac.v90.i3.20516","article-title":"High lipoprotein(a) levels and risk of aortic valve stenosis related clinical event: a systematic review","volume":"90","author":"Masson","year":"2022","journal-title":"Rev Argent Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacc.2022.05.032","article-title":"Mitral valve dysfunction in patients with annular calcification: JACC review topic of the week","volume":"80","author":"Churchill","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2023.01.025_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ehjci\/jev338","article-title":"Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease","volume":"17","author":"Hojo","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.numecd.2023.01.025_bib10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/heartjnl-2016-309404","article-title":"Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults","volume":"102","author":"Bortnick","year":"2016","journal-title":"Heart"},{"issue":"11_Supplement","key":"10.1016\/j.numecd.2023.01.025_bib11","doi-asserted-by":"crossref","first-page":"A1778","DOI":"10.1016\/S0735-1097(18)32319-2","article-title":"The relationship between lipoprotein (a), mitral annular calcification, and mitral stenosis in a large cohort of dyslipidemia patients","volume":"71","author":"Shah","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003354","article-title":"Associations of genetically predicted lp(a) (lipoprotein [a]) levels with cardiovascular traits in individuals of European and african ancestry","volume":"14","author":"Satterfield","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.numecd.2023.01.025_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcct.2020.06.002","article-title":"Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: the Multi-Ethnic Study of Atherosclerosis","volume":"15","author":"Garg","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.numecd.2023.01.025_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2021.11.029","article-title":"Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: the Copenhagen General Population Study","volume":"349","author":"Kaltoft","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2023.01.025_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024870","article-title":"Lipoprotein(a) and subclinical vascular and valvular calcification on cardiac computed tomography: the atherosclerosis risk in communities study","volume":"11","author":"Obisesan","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2023.01.025_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamasurg.2021.0546","article-title":"PRISMA reporting guidelines for meta-analyses and systematic reviews","volume":"156","author":"Arya","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.numecd.2023.01.025_bib17","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"26","key":"10.1016\/j.numecd.2023.01.025_bib18","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2023.01.025_bib19","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.jacc.2015.08.872","article-title":"Mitral annulus calcification","volume":"66","author":"Abramowitz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.105.552844","article-title":"Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis","volume":"113","author":"Allison","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.01.025_bib21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/2047487319830485","article-title":"Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: a review of the evidence","volume":"26","author":"Faggiano","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.amjcard.2005.11.086","article-title":"Relations of inflammation and novel risk factors to valvular calcification","volume":"97","author":"Fox","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11883-020-0825-3","article-title":"Mitral annular calcification: association with atherosclerosis and clinical implications","volume":"22","author":"Cavalcanti","year":"2020","journal-title":"Curr Atherosclerosis Rep"},{"key":"10.1016\/j.numecd.2023.01.025_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.01.025_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2022.04.004","article-title":"Lipoprotein(a): an underestimated inflammatory mastermind","volume":"349","author":"Dzobo","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2023.01.025_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/eurheartj\/ehab757","article-title":"Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.01.025_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacbts.2017.03.015","article-title":"Lipoprotein(a) induces human aortic valve interstitial cell calcification","volume":"2","author":"Yu","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.numecd.2023.01.025_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5115\/acb.20.093","article-title":"Histological assessment of the human heart valves and its relationship with age","volume":"53","author":"Gumpangseth","year":"2020","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.numecd.2023.01.025_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2022.06.019","article-title":"Ancestry, lipoprotein(a), and cardiovascular risk thresholds: JACC review topic of the week","volume":"80","author":"Tsimikas","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11886-017-0883-5","article-title":"Mitral valve disease: a comprehensive review","volume":"19","author":"Harb","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"13","key":"10.1016\/j.numecd.2023.01.025_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease","volume":"24","author":"Iung","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.numecd.2023.01.025_bib32","first-page":"517","article-title":"Epidemiology of valvular heart disease","volume":"102","author":"Peters","year":"2022","journal-title":"Surg Clin"},{"key":"10.1016\/j.numecd.2023.01.025_bib33","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10237-012-0462-z","article-title":"Mechanics of the mitral valve: a critical review, an in\u00a0vivo parameter identification, and the effect of prestrain","volume":"12","author":"Rausch","year":"2013","journal-title":"Biomech Model Mechanobiol"},{"key":"10.1016\/j.numecd.2023.01.025_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ijms24010170","article-title":"Lipoprotein(a): Cardiovascular disease, aortic stenosis and new therapeutic option","volume":"24","author":"Maloberti","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:23:52Z","timestamp":1760545432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0939475323000625"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.01.025","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High lipoprotein(a) levels and mitral valve disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}